{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:52:33Z","timestamp":1648695153952},"reference-count":0,"publisher":"Dustri-Verlgag Dr. Karl Feistle","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CP"],"published-print":{"date-parts":[[2010,7,1]]},"DOI":"10.5414\/cpp48462","type":"journal-article","created":{"date-parts":[[2011,3,25]],"date-time":"2011-03-25T08:47:27Z","timestamp":1301042847000},"page":"462-464","source":"Crossref","is-referenced-by-count":1,"title":["Rat monoclonal antibodies against bone sialoprotein II inhibit tumor growth and osteolytic lesions in nude rats induced by MDA-MB-231 breast cancer cells"],"prefix":"10.5414","volume":"48","author":[{"given":"M.","family":"Zepp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.P.","family":"Armbruster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3374","container-title":["Int. Journal of Clinical Pharmacology and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2013,9,6]],"date-time":"2013-09-06T10:36:31Z","timestamp":1378463791000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dustri.com\/article_response_page.html?artId=7665&doi=10.5414\/CPP48462&L=0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":0,"journal-issue":{"issue":"07","published-print":{"date-parts":[[2010]]}},"alternative-id":["48462"],"URL":"https:\/\/doi.org\/10.5414\/cpp48462","relation":{},"ISSN":["0946-1965"],"issn-type":[{"value":"0946-1965","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7,1]]}}}